Status:
COMPLETED
Oral Microbiome and Pancreatic Cancer
Lead Sponsor:
NYU Langone Health
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
55-74 years
Brief Summary
This is a prospective population based study to examine the relationship of oral and pancreatic microbiome, and their functions, to pancreatic cancer risk. The identification of specific oral bacteri...
Detailed Description
A history of periodontal disease and the presence of circulating antibodies to selected oral pathogens have been associated with increased risk of pancreatic cancer; however, direct relationships of o...
Eligibility Criteria
Inclusion
- DNA extracted from oral wash samples from NIH-PLCO and ACS-CPS cohorts
Exclusion
- \-
Key Trial Info
Start Date :
December 1 1992
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
732 Patients enrolled
Trial Details
Trial ID
NCT03302637
Start Date
December 1 1992
End Date
December 1 2010
Last Update
October 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016